Literature DB >> 30395692

Cardiovascular Autonomic Neuropathy as a New Complication of Postsurgical Chronic Hypoparathyroidism.

Gaia Tabacco1, Anda Mihaela Naciu1, Daria Maggi1, Assunta Santonati2, Claudio Pedone3, Roberto Cesareo4, Daniela Bosco2, Gianluigi Gaspa4, Nicola Napoli1,5, Paolo Pozzilli1, Silvia Manfrini1, Andrea Palermo1.   

Abstract

Postsurgical hypoparathyroidism (hypoPT) increases fatigue and seems to affect the risk of mortality. Cardiovascular autonomic neuropathy (CAN) is an impairment of the cardiovascular autonomic system, a cause of increased mortality, and associated with increased fatigability. The aim of this study is to evaluate CAN in hypoPT and its relationship with hypocalcemia, PTH levels, and hyperphosphatemia. This is a cross-sectional study comparing 51 postsurgical hypoPT patients treated with calcium and calcitriol and 43 control subjects without any PTH/calcium/phosphate disorders who underwent thyroidectomy. CAN was assessed by heart rate (HR) response to deep breathing, HR response to the lying-to-standing test, HR response to the Valsalva maneuver, and blood pressure response to standing. Participants were considered to have "early CAN" if they had one abnormal result in the HR tests and "definite CAN" with two or more abnormal results. The prevalence of CAN was 23% in the control group and 78% in the hypoPT group (OR 11.48; 95% CI, 4.48 to 32.17). Patients with hypoPT and serum calcium (sCa) ≥8.5 mg/dL had a prevalence of early CAN of 72.4% and the prevalence was 86.4% in those with sCa <8.5 mg/dL. Definite CAN was found in 2.3% of the control group, 24.1% of the hypoPT group without hypocalcemia, and 59.1% of the hypoPT group with hypocalcemia. In the hypoPT group, the OR for definite CAN in the patients with hypocalcemia compared to the patients with normocalcemia was 4.54 (95% CI, 1.36 to 15.11). The association between low sCa and definite CAN was confirmed after adjustment for confounders with OR 13.62 (95% CI, 2.12 to 149.84). No association was found between definite CAN and PTH levels or high phosphate levels. HypoPT is associated with CAN and hypocalcemia seems to affect its severity. Larger and prospective studies are needed to confirm our findings.
© 2018 American Society for Bone and Mineral Research. © 2018 American Society for Bone and Mineral Research.

Entities:  

Keywords:  CARDIOVASCULAR AUTONOMIC NEUROPATHY; HYPOCALCEMIA; HYPOPARATHYROIDISM; PTH

Mesh:

Substances:

Year:  2018        PMID: 30395692     DOI: 10.1002/jbmr.3623

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  5 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

2.  Cardiovascular autonomic neuropathy as a cause of fatigue in chronic hypoparathyroidism.

Authors:  Gaia Tabacco; Anda Mihaela Naciu; Roberto Cesareo; Daria Maggi; Claudio Pedone; Diana Lelli; Assunta Santonati; Daniela Bosco; Alfonso Maria Di Tommaso; Paolo Pozzilli; Silvia Manfrini; Andrea Palermo
Journal:  Endocrine       Date:  2019-10-03       Impact factor: 3.633

3.  The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics.

Authors:  Neil Gittoes; Lars Rejnmark; Steven W Ing; Maria Luisa Brandi; Sigridur Björnsdottir; Stefanie Hahner; Lorenz C Hofbauer; Pascal Houillier; Aliya A Khan; Michael A Levine; Michael Mannstadt; Dolores M Shoback; Tamara J Vokes; Pinggao Zhang; Claudio Marelli; John Germak; Bart L Clarke
Journal:  BMC Endocr Disord       Date:  2021-11-20       Impact factor: 2.763

4.  Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study.

Authors:  Olulade Ayodele; Fan Mu; Richard Berman; Elyse Swallow; Lars Rejnmark; Elvira O Gosmanova; Sanjiv Kaul
Journal:  Adv Ther       Date:  2022-06-11       Impact factor: 4.070

5.  Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials.

Authors:  Giulia Puliani; Valeria Hasenmajer; Ilaria Simonelli; Valentina Sada; Riccardo Pofi; Marianna Minnetti; Alessia Cozzolino; Nicola Napoli; Patrizio Pasqualetti; Daniele Gianfrilli; Andrea M Isidori
Journal:  J Bone Miner Res       Date:  2022-05-20       Impact factor: 6.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.